IP Library Granted Patent US 10,139,408
Granted Patent B2
US 10,139,408 · App. 15/314,240 · Granted Nov 27, 2018

Method for diagnostics, treatment and prevention of Parkinson's disease

Inventors: Filip Scheperjans (Helsinki, FI); Petri Auvinen (Helsinki, FI); Velma Aho (Helsinki, FI); Pedro Pereira (Helsinki, FI); Kaisa Koskinen (Graz, AT); Lars Paulin (Helsinki, FI)
Assignee: NeuroInnovation Oy
G01N33/56911A61K35/741C12Q1/04G01N33/6896G01N2800/2835G01N2800/50Y02A50/475
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,139,408
App. No.
15/314,240
Granted
Nov 27, 2018
Kind
B2
Abstract

The present invention relates to the field of medicine and in particular to Parkinson's disease (PD). Specifically the present invention relates to methods and means for early detection of PD. The invention relates also to methods and means for treatment or prophylaxis of PD. In the method of the invention a probability of a subject developing or having Parkinson's disease (PD) is determined by measuring the relative abundances of one or multiple microbial tax a in a sample from a subject; and the probability of the subject developing or having PD is determined based on the measured abundances. The present invention provides a novel approach for the diagnostics of PD.

Claims (10)

1. A method for measuring the probability of a subject developing or having Parkinson's disease (PD) characterized by a prodromal and premotor period in which the subject has no motor symptoms, the method comprising

a) obtaining a fecal sample from the subject;

b) measuring the abundances of at least Prevotellaceae bacteria in the sample; and

c) determining the probability of the subject developing or having PD based on the abundances measured in step b),

wherein a high abundance of said Prevotellaceae in relation to other bacteria in the sample indicates a low probability of the subject developing or having PD.

2. The method according to claim 1 , wherein the subject is human.

3. The method according to claim 1 , wherein the bacteria comprise Prevotella.

4. The method according to claim 1 , where the bacteria is one or more of Prevotella amnii, Prevotella bergensis, Prevotella bivia, Prevotella bryantii, Prevotella buccae, Prevotella buccalis, Prevotella copri, Prevotella disiens, Prevotella marshii, Prevotella melaninogenica, Prevotella oralis, Prevotella oris, Prevotella ruminicola, Prevotella salivae, Prevotella sp oral taxon 299 , Prevotella sp oral taxon 317 , Prevotella sp oral taxon 472 , Prevotella tannerae, Prevotella timonensis or Prevotella veroralis.

5. The method according to claim 1 , wherein low abundance of Prevotellaceae and high relative abundance of one or more of Lactobacillaceae, Verrucomicrobiaceae, Bradyrhizobiaceae, Clostridiales Incertae Sedis IV, Bacteroidaceae or Ruminococcaceae in relation to other bacteria in the sample indicates a high probability of the subject developing or having PD.

6. The method of claim 1 , wherein relative abundances of further bacteria are measured and low relative abundance of Prevotella or Prevotellaceae and of one or more of Bacteroidia, Clostridiaceae, Clostridium sensu stricto, Faecalibacterium, Mogibacterium, Oscillibacter, Sutterella and Roseburia in relation to other bacteria in the sample and the high relative abundance of one or more of the bacteria selected from the following group: Acetivibrio, Actinobacteria, Allobaculum, Agromonas, Anaerotruncus, Bacteroides, Blautia, Butyricicoccus, Clostridium IV, Collinsella, Coriobacteriaceae, Coriobacteriales, Eggerthella, Firmicutes, Lactobacillus, Lachnospiraceae, Mahella, Parabacteroides, Phaeovibrio, Porphyromonadaceae, Ruminococcaceae, Oscillibacter, Saccharofermentans or Sporobacterium in relation to other bacteria in the sample, indicates a high probability of the subject developing or having PD.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2020
From: NEUROINNOVATION OY
To: NEUROBIOME OY
Reel/Frame 053757/0300 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2017
From: SCHEPERJANS, FILIP; AUVINEN, PETRI; AHO, VELMA; PEREIRA, PEDRO; KOSKINEN, KAISA; PAULIN, LARS
To: NEUROINNOVATION OY
Reel/Frame 041353/0568 →
Priority Claims (1)
FI 20145492 · May 28, 2014 · national
Continuity (1)
Related Publication 20170191998A1 · Jul 6, 2017